title: Central nervous system toxicity and amprenavir oral solution.
authors.forename: Christopher W
authors.initials: CW
authors.lastname: James
authors.forename: Kelly C
authors.initials: KC
authors.lastname: McNelis
authors.forename: Monica D
authors.initials: MD
authors.lastname: Matalia
authors.forename: David M
authors.initials: DM
authors.lastname: Cohen
authors.forename: Susan
authors.initials: S
authors.lastname: Szabo
mesh_terms: D002219:Carbamates; D005663:Furans; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000523:psychology*; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir